Provectus Algae

Find the latest for Provectus Algae company news

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Building mycotoxin-resilient supply chains with AI

Mycotoxins have long been a pervasive challenge in agriculture and food production, threatening both animal and human health. As naturally occurring

TraceGains uses AI to target food quality, safety

The tech platform said producers can better detect contamination and allergens with its program in order to achieve compliance.

Secure AI Collaboration Will Fine-Tune OpenFold3 with Proprietary Data

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

AI accelerating medical research; Solving pain points in sales

Beyond speed, AI has also helped reduce costs. Conventional methods required nearly $35,000 per genome analysis, but AI-driven models running on GPUs have lowered the cost to under $2,000, making high-quality genomic research more accessible.

AI hardware 7month
Cone snail toxin has inspired a breakthrough in drug discovery

AI helps scientists decode a cone snail toxin's targets, paving the way for safer drug development and ecological research.

How AI is Transforming Protein Folding and Solving Global Challenges in Medicine and Sustainability

Discover how AI tools like AlphaFold and RF Diffusion are revolutionizing protein folding design, medicine, and sustainability for a better

Capgemini's AI Breakthrough to Accelerate Bioeconomy

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while using 99% less data than traditional methods.